Research, data analysis, and commentary on abortion and declining birth rates.
Medical abortion doesn't always work; it is well established that MA has an expected treatment failure rate of about 6%. Which means that as many as 1-in-17 pregnant women using abortion pills will subsequently need hospital treatment for complications arising from an incomplete abortion. Ranbaxy (UK) Limited is the manufacturer of Medabon, the mifepristone/misoprostol combination... Continue Reading →
Gynuity Health Projects, a pro-abortion activist organisation, recently published results from its own study into the safety and efficacy of telemedicine abortion. Two key findings are: Six percent of women using abortion pills at home, subsequently needed hospital treatment because of complications related to the abortion, a rate of 1-in-17. Four percent of women using... Continue Reading →
